Presentation is loading. Please wait.

Presentation is loading. Please wait.

Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes  Diana Mina, Kirsten L. Johansen, Charles E. McCulloch,

Similar presentations


Presentation on theme: "Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes  Diana Mina, Kirsten L. Johansen, Charles E. McCulloch,"— Presentation transcript:

1 Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes  Diana Mina, Kirsten L. Johansen, Charles E. McCulloch, Michael A. Steinman, Barbara A. Grimes, Julie H. Ishida  American Journal of Kidney Diseases  Volume 73, Issue 4, Pages (April 2019) DOI: /j.ajkd Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

2 Figure 1 Cohort selection. ∗Patients were additionally excluded if any of the following events occurred in January 2011: death, kidney transplantation, change in modality away from in-center hemodialysis, uncertain/recovered kidney function, loss to follow-up, withdrawal from dialysis therapy, or loss of Part D coverage, which precluded our ability to ascertain exposure status as of February Abbreviations: BMI, body mass index; VA, Veterans Affairs. American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions


Download ppt "Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes  Diana Mina, Kirsten L. Johansen, Charles E. McCulloch,"

Similar presentations


Ads by Google